drugset / Trial / NCT00049959

Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.

NCT00049959

Phase 3 Terminated QLT Inc. Novartis · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the two studies is to determine whether an experimental therapy using a photoactive drug, verteporfin, in combination with direct light exposure of basal cell carcinoma of the skin can safely eliminate these skin tumors.

Timeline

Start
Primary completion
2004-03
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Verteporfin Other / unclassified Intravenous